Skip to main content
Pure Biologics S.A. logo

Pure Biologics S.A. — Investor Relations & Filings

Ticker · PUR ISIN · PLPRBLG00010 LEI · 2594002TXS19AUYHIF82 WAR Manufacturing
Open in API
Filings indexed 515 across all filing types
Latest filing 2023-01-30 Major Shareholding Noti…
Country PL Poland
Listing WAR PUR

About Pure Biologics S.A.

https://purebiologics.com/

Pure Biologics S.A. is a biopharmaceutical company engaged in the discovery and development of novel biological drugs and non-systemic therapies. The company leverages its expertise in antibody and aptamer technologies to create innovative treatments. Its therapeutic portfolio is primarily focused on immuno-oncology. A key aspect of its strategy is the development of original, non-generic and non-biosimilar, biological drug candidates.

Recent filings

Filing Released Lang Actions
Zawiadomienie na podstawie art. 69 Ustawy o Ofercie_Filip Jelen
Major Shareholding Notification Classification · 99% confidence The document is a formal notification ('ZAWIADOMIENIE') submitted to the Polish Financial Supervision Authority ('Komisja Nadzoru Finansowego' - KNF) by an individual, Filip Jeleń. The content explicitly states that the notification is made in execution of the obligation under Article 69(1)(1) of the Polish Act on Public Offering. It details a change in shareholding percentage (from 0.81% to 8.59%) resulting from a transaction (return of loaned shares). This type of mandatory disclosure regarding changes in significant share ownership thresholds (crossing the 5% mark) directly corresponds to the definition of a Major Shareholding Notification.
2023-01-30 Polish
Zawiadomienie na podstawie art. 69 Ustawy o Ofercie_Unisono Capital
Major Shareholding Notification Classification · 99% confidence The document is a formal notification ("ZAWIADOMIENIE") submitted to the Polish Financial Supervision Authority ("URZĄD KOMISJI NADZORU FINANSOWEGO") by Unisono Capital regarding a change in its shareholding in PURE BIOLOGICS Spółka Akcyjna. The notification explicitly references Article 69 of the Polish Public Offering Act, which governs notifications of changes in significant shareholdings. The content details the exact number of shares held before and after a transaction (a return of loaned shares), resulting in the shareholder's stake dropping below 15%, 10%, and 5% thresholds. This structure and content perfectly match the definition of a Major Shareholding Notification.
2023-01-30 Polish
Zawiadomienia o zmianie stanu posiadania akcji Spółki - Content (PL)
Major Shareholding Notification Classification · 99% confidence The document text is very short (672 characters) and explicitly states that the company 'otrzymał... zawiadomienia o zmianie stanu posiadania akcji Spółki' (received notifications about a change in the holding of the Company's shares) from specific individuals/entities, and that the content of these notifications is provided 'w załączeniu do niniejszego raportu bieżącego' (attached to this current report). This structure—announcing receipt of insider transaction notifications and attaching the details—strongly suggests a filing related to insider trading or major shareholding changes. Since the content concerns changes in share ownership by individuals/entities (Filip Jeleń and UNISONO CAPITAL), the most appropriate category is Major Shareholding Notification (MRQ) or Director's Dealing (DIRS). Given the context of 'zmianie stanu posiadania akcji' (change in shareholding status) reported under Article 69 of the Polish Public Offering Act, MRQ (Major Shareholding Notification) is the most precise fit, as DIRS usually refers specifically to directors' personal trades, whereas this covers significant holdings generally. However, since the text is an announcement *about* the filing rather than the filing itself, and it's a regulatory notification, RNS could be considered under the 'MENU VS MEAL' rule if MRQ/DIRS were not available. Since MRQ is available and directly relates to changes in significant share ownership, I will classify it as MRQ, acknowledging the short nature might suggest RPA/RNS, but the content is highly specific to MRQ.
2023-01-30 Polish
Powiadomienie na podstawie art. 19 MAR_Andrzej Trznadel
Director's Dealing Classification · 100% confidence The document is titled "Powiadomienie o transakcji/ transakcjach*, o których mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of a transaction/transactions referred to in Article 19(1) of the MAR Regulation). Article 19 of the Market Abuse Regulation (MAR) mandates reporting of transactions conducted by persons discharging managerial responsibilities (PDMRs). The content details a transaction involving an individual (Andrzej Trznadel, Chairman of the Supervisory Board) and shares of the company (Pure Biologics Spółka Akcyjna), including transaction type ('Zwrot pożyczki akcji' - Return of a share loan), price, and volume. This directly corresponds to the definition of Director's Dealing (insider trades by executives/directors). Therefore, the appropriate classification is DIRS.
2023-01-30 Polish
Powiadomienie na podstawie art. 19 MAR_Filip Jelen
Director's Dealing Classification · 100% confidence The document is titled "Powiadomienie o transakcji/transakcjach*, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of transaction(s) referred to in Article 19(1) of the MAR Regulation). It details a transaction involving shares by a member of management ('Filip Jeleń', 'Prezes Zarządu Spółki' - CEO/President of the Management Board). This structure and content directly correspond to insider trading notifications required under the Market Abuse Regulation (MAR). Among the provided definitions, 'Director's Dealing' (DIRS) is the most appropriate category for reporting personal share transactions by company directors and executives.
2023-01-30 Polish
Powiadomienia o transakcjach wykonywanych na akcjach Spółki - Content (PL)
Director's Dealing Classification · 100% confidence The document text is very short (465 characters) and explicitly states that the Management Board received notifications regarding transactions executed on the company's shares from the CEO and the Chairman of the Supervisory Board. It concludes by stating that the content of these notifications is provided in the attachment to this current report ('raport bieżący'). This structure—announcing receipt of insider transaction reports and attaching the details—strongly suggests a filing related to insider trading disclosures. The closest specific category is 'Director's Dealing' (DIRS). However, since the document itself is merely an announcement that the details are attached, and given the short length, it could potentially be classified as a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS) if DIRS is reserved for the actual transaction details. Given the content is explicitly about transactions by management/supervisors, DIRS is the most accurate thematic fit, even if it's an announcement wrapper. I will classify it as DIRS as the core subject matter is director dealings.
2023-01-30 Polish

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.